Medicxi, a European investment firm focused on the life sciences sector, has closed Medicxi V, a €500m (US$581m) fund dedicated to building and backing innovative biotechnology companies. The oversubscribed fund…
UK: Medicxi closes oversubscribed Fund V at €500m
…
…






